While Charles River Laboratories International Inc has overperformed by 0.74%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CRL fell by -17.27%, with highs and lows ranging from $230.02 to $91.86, whereas the simple moving average fell by -3.13% in the last 200 days.
On September 09, 2025, Jefferies Upgraded Charles River Laboratories International Inc (NYSE: CRL) to Buy. A report published by Citigroup on July 09, 2025, Upgraded its rating to ‘Buy’ for CRL. Redburn Atlantic also Upgraded CRL shares as ‘Buy’, setting a target price of $182 on the company’s shares in a report dated May 23, 2025. Evercore ISI May 08, 2025d its ‘In-line’ rating to ‘Outperform’ for CRL, as published in its report on May 08, 2025. Goldman’s report from March 21, 2025 suggests a price prediction of $170 for CRL shares, giving the stock a ‘Neutral’ rating. Citigroup also rated the stock as ‘Neutral’.
Analysis of Charles River Laboratories International Inc (CRL)
Further, the quarter-over-quarter increase in sales is 0.59%, showing a positive trend in the upcoming months.
Charles River Laboratories International Inc’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -1.96% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.10, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and CRL is registering an average volume of 874.81K. On a monthly basis, the volatility of the stock is set at 3.49%, whereas on a weekly basis, it is put at 3.08%, with a loss of -0.36% over the past seven days. Furthermore, long-term investors anticipate a median target price of $179.36, showing growth from the present price of $152.72, which can serve as yet another indication of whether CRL is worth investing in or should be passed over.
How Do You Analyze Charles River Laboratories International Inc Shares?
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.12%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 104.11% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
